Skip to content
Home
About us
Team
Investments
Investor Relations
ESG
News
Meet us
align-justify
Menu
Home
About us
Team
Investments
Investor Relations
ESG
News
Meet us
user-group
INVESTOR ACCESS
Search
Search
Close this search box.
apps
Menu
Home
About us
Team
Investments
Investor Relations
ESG
News
Meet us
Home
/
Sitemap
arrow-left
Back to Homepage
Sitemap
Pages
About us
ESG
Investments
Investor Relations
Legal informations
Meet us
Merieux Partners – Home
News
News-Buyout
News-Venture-Capital
Sitemap
Team
Catégories
Acquisitions & Partnerships
Appointments
Awards
Board
Buyout
Financial Results
Investment
Investor Relations
News
Opérations
Others
Recent investments & divestments
Regulatory & Product Launch
Venture Capital
Team Members
Aida Ndiaye
Alexandre Mérieux
Bertrand Rambaud
Christine Demode
Florent Rosset
Guillaume Martignoni
Guillaume Thoviste
Jaana Grüter
Jean Chatillon
Jean-François Billet
Jonathan Dupont
Justine Chabrol
Karina Remini-Alik
Laurent Mercier
Marie-Justine Lecomte
Marion Gartner
Michel Baguenault
Quentin de Labarre
Romain Blache
Theodor Wuppermann
Thierry Chignon
Valérie Calenda
Yoann Bonnamour
Investments
AcuSurgical
Advencis
Amplitude Systèmes
Amyl Therapeutics
Biobest
Broken String Biosciences
Cairdac
Cell-Easy
CEVA Santé Animale
Deepull
Dental Monitoring
DOC Generici
Domus VI
Elsan
GTP Bioways
InnoSyn
Inscripta
Ivantis
Janvier Labs
Kalila Medical
KeepMED
Keranova
Laboratoires INELDEA
LabQuality
Lavorel Medicare
LNA Santé
Mablink Bioscience
Mabtech
Mimetas
MRM Health
Neurinnov
Nutragroup
Origene
Physioassist
Piercan
Plantex
Prodigest
Quantalife
Seqens
SeqOne Genomics
SERB Pharmaceuticals
SGH Medical Pharma
Supersonic Imagine
SWIXX BioPharma
TARA Biosystems
Theravia
Triple Ring Technologies
TWIST Bioscience
XERIS Pharmaceuticals
Posts
AcuSurgical, a French Robotics Company Developing a Novel Solutionfor Retinal Micro-Surgery, Announces Successful Completion of FirstClinical Study
Amyl Therapeutics receives additional €5M funding to advance therapeutic platform
BIOBEST acquires a 60% stake in Biopartner
Biobest Group acquires full ownership in Biobest Antalya
Biobest signs agreement with Aqua Capital and GIC to acquire Biotrop in Brazil
Biobest signs agreement with Aqua Capital and GIC to acquire Biotrop in Brazil
Biobest, Aqua-Capital and GIC acquires Biotrop in Brazil
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage.
Broken String Biosciences Series A fundraising
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization
CEVA celebrates 100 years of developing animal vaccines at its Dessau site in Germany
CEVA SANTÉ ANIMALE announces Japan-based Joint Venture with Mitsui
Deepull appoints Didier Deltort to its Board of Directors.
Dr Jeanne Bolger, the new Chair of AstriVax
Integrating Nature: at the heart of our “One Health” approach.
Jean-Guillaume LAFAY, Former CEO of Mablink, joins Mérieux Equity Partners Innovation Team as Operating Partner
Job Offer for a permanent contract – Project Management Officer
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform
Labquality strengthens its regulatory affairs service capabilities and expands to Sweden.
Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners
Mablink Bioscience Enters an Agreement to be Acquired by Lilly
Mérieux Equity Partners acquires a majority stake in Labquality
Mérieux Equity Partners acquires a majority stake in Piercan.
Merieux Equity Partners and IK Partners to sell Mabtech to EQT
Merieux Equity Partners announces the first two exits of Mérieux Participations 3
Mérieux Equity Partners announces the sale of the French Contract Developing and Manufacturing Organisation GTP Bioways to the Italian company Olon Group
Mérieux Equity Partners announces two promotions to strengthen its Buyout Team
MERIEUX EQUITY PARTNERS becomes an Investor Member of the European Healthcare Private Equity Association
Mérieux Equity Partners Closes Mérieux Participations 4 (“MP4”) Above Target and Welcomes New Team Members for Growth Buy-Out investment team, ESG and Investor Relations.
Mérieux Equity Partners invests in Janvier Labs
Mérieux Equity Partners is pleased to confirm the very strong momentum of its newest investment fund, Mérieux Participations 4 (“MP4”), a 500 million launched in May 2021.
Mérieux Equity Partners is very pleased to contribute to the development of La Maison du Bien Commun
MERIEUX EQUITY PARTNERS joins iC International
Mérieux Equity Partners to partner with – through acquiring a majority stake in – InnoSyn
MIMETAS participates in €325 M Oncode-PACT initiative to accelerate and improve oncology drug development
MRM Health and IFF Reach Second Milestone in the partnered Type 2 Diabetes program
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
MRM Health Appoints Katja Conrath as Chief Scientific Officer
MRM Health Initiates Clinical Research in Parkinson’s Disease
MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis
MRM Health starts clinical trial Pouchitis
MRM Health to Present Positive Clinical Data from MH002 in Ulcerative Colitis at Digestive Disease Week (DDW)
PhysioAssist announces successful acquisition by Inogen Inc.
Private Corner lance un feeder sur le thème de la santé avec Mérieux Equity Partners, pour son fonds Mérieux Innovation 2
SOS Uganda Initiative
The Mérieux Innovation 2 fund is awarded the Tibi label, in recognition of its support to healthcare innovation in France and Europe, for the benefit of patients.
TRIPLE RING TECHNOLOGIES and One Health Group Announce Tech Partnership
World’s first clinical stage bi-manual ophthalmology robot successfully completes retinal surgery case
arrow-left
Back to Homepage